A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects.
Clinical trial NCT03128606 · COMPLETED
Trial details
- NCT number
- NCT03128606
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2018-02-20
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.